These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12952475)

  • 1. RAMPED-UP NMR: multiplexed NMR-based screening for drug discovery.
    Zartler ER; Hanson J; Jones BE; Kline AD; Martin G; Mo H; Shapiro MJ; Wang R; Wu H; Yan J
    J Am Chem Soc; 2003 Sep; 125(36):10941-6. PubMed ID: 12952475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and NMR-based screening of LEF, a library of chemical fragments with different local environment of fluorine.
    Vulpetti A; Hommel U; Landrum G; Lewis R; Dalvit C
    J Am Chem Soc; 2009 Sep; 131(36):12949-59. PubMed ID: 19702332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust NMR screening for lead compounds using tryptophan-containing proteins.
    Bista M; Kowalska K; Janczyk W; Dömling A; Holak TA
    J Am Chem Soc; 2009 Jun; 131(22):7500-1. PubMed ID: 19422216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR in the acceleration of drug discovery.
    Sem DS; Pellecchia M
    Curr Opin Drug Discov Devel; 2001 Jul; 4(4):479-92. PubMed ID: 11727313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear magnetic resonance in target profiling and compound file enhancement.
    Sun C; Hajduk PJ
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):463-70. PubMed ID: 16889229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 19F NMR spectroscopy to screen chemical libraries for ligands that bind to proteins.
    Tengel T; Fex T; Emtenas H; Almqvist F; Sethson I; Kihlberg J
    Org Biomol Chem; 2004 Mar; 2(5):725-31. PubMed ID: 14985813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration measurements by PULCON using X-filtered or 2D NMR spectra.
    Dreier L; Wider G
    Magn Reson Chem; 2006 Jul; 44 Spec No():S206-12. PubMed ID: 16823904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TINS, target immobilized NMR screening: an efficient and sensitive method for ligand discovery.
    Vanwetswinkel S; Heetebrij RJ; van Duynhoven J; Hollander JG; Filippov DV; Hajduk PJ; Siegal G
    Chem Biol; 2005 Feb; 12(2):207-16. PubMed ID: 15734648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorine-NMR experiments for high-throughput screening: theoretical aspects, practical considerations, and range of applicability.
    Dalvit C; Fagerness PE; Hadden DT; Sarver RW; Stockman BJ
    J Am Chem Soc; 2003 Jun; 125(25):7696-703. PubMed ID: 12812511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redesign of protein domains using one-bead-one-compound combinatorial chemistry.
    Pastor JJ; Granados G; Carulla N; Rabanal F; Giralt E
    J Am Chem Soc; 2007 Dec; 129(48):14922-32. PubMed ID: 17990878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR spectroscopy tools for structure-aided drug design.
    Homans SW
    Angew Chem Int Ed Engl; 2004 Jan; 43(3):290-300. PubMed ID: 14705081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR fragment screening: Advantages and applications.
    Schade M
    IDrugs; 2006 Feb; 9(2):110-3. PubMed ID: 16523400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical aspects of NMR-based fragment screening.
    Lepre CA
    Methods Enzymol; 2011; 493():219-39. PubMed ID: 21371593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refinement of NMR structures using implicit solvent and advanced sampling techniques.
    Chen J; Im W; Brooks CL
    J Am Chem Soc; 2004 Dec; 126(49):16038-47. PubMed ID: 15584737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
    Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
    J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope mapping and competitive binding of HSA drug site II ligands by NMR diffusion measurements.
    Lucas LH; Price KE; Larive CK
    J Am Chem Soc; 2004 Nov; 126(43):14258-66. PubMed ID: 15506793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A straightforward NMR-spectroscopy-based method for rapid library screening.
    Siriwardena AH; Tian F; Noble S; Prestegard JH
    Angew Chem Int Ed Engl; 2002 Sep; 41(18):3454-7. PubMed ID: 12298062
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid protein-ligand costructures using chemical shift perturbations.
    Stark J; Powers R
    J Am Chem Soc; 2008 Jan; 130(2):535-45. PubMed ID: 18088118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectively labeling the heterologous protein in Escherichia coli for NMR studies: a strategy to speed up NMR spectroscopy.
    Almeida FC; Amorim GC; Moreau VH; Sousa VO; Creazola AT; Américo TA; Pais AP; Leite A; Netto LE; Giordano RJ; Valente AP
    J Magn Reson; 2001 Jan; 148(1):142-6. PubMed ID: 11133287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new strategy for improved secondary screening and lead optimization using high-resolution SPR characterization of compound-target interactions.
    Huber W
    J Mol Recognit; 2005; 18(4):273-81. PubMed ID: 15997470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.